analytics_image
Vantage Market Research
Vantage Market Research

Reports - Epigenetics Market

iconBiotechnology and Life Sciences

Epigenetics Market

Epigenetics Market by Product (Instruments, Reagents & Kits, Others), by Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases), by Technology (Methylation, Acetylation, Phosphorylation, Other Technologies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 2.56 Billion

Market Size By 2035

USD 9.11 Billion

CAGR (2025 - 2035)

12.24%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Product, By Application, By Technology, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

The global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 12.24% between 2025 and 2035.

Market Synopsis:

Epigenetics Market Size, 2024 To 2035 (USD Billion)

The increased prevalence of cancer and other chronic diseases, as well as the ageing population, are expected to drive market expansion. The presence of institutions like the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institute of Health (NIH) is helping the industry flourish. These groups advocate for funding and support for Epigenetics -related R&D and product development. The National Institutes of Health has a common fund epigenomics initiative that actively encourages innovative Epigenetics research around the world.

COVID-19s increased prevalence is expected to have an impact on market growth over the projection period. The COVID-19 dilemma has had a significant and immediate impact on the healthcare industry. Because of the unexpected impact on the supply chain and the limits imposed on manufacturing and supply operations during the early stages of the Corona virus pandemic, most pharmaceutical and nutraceutical companies suffered a minor loss in the first few quarters. COVID-19, on the other hand, has raised demand for Epigenetics, and some important players have seen favorable sales growth as a result of the increased demand.


Rising Cancer Prevalence

There has been a huge increase in the number of people diagnosed with cancer around the world. According to WHO forecasts, the number of cancer patients is predicted to rise from 14.1 million in 2012 to 19.3 million by 2025. Cancer formation and progression are linked to Epigenetics, alterations such as DNA methylation dysregulation. Epigenetics opens up new avenues for developing therapeutic treatments to counteract cancer deregulation. Several cancer research studies using Epigenetics, approaches are now underway, and significant funding is being allocated to these investigations.


High Cost of Instruments

Instruments necessary for epigenetics research are costly since they have advanced features and functions. The NovaSeq 5000 and 6000 sequencers from Illumina, for example, are priced at USD 850,000 and USD 985,000, respectively, and were released in January 2017. Maintenance and a variety of additional indirect costs, such as samples and consumables, add to the overall cost of ownership. Many of these systems are required by pharmaceutical corporations and research institutes. As a result, large sums of money will be needed to purchase a number of high-priced genomic devices. End users with limited budgets, such as academic research laboratories, find it challenging to afford such systems. As a result of the high costs of instruments, their widespread acceptance is hampered, which is projected to limit market growth over the projection period.


Market Segmentation:

The Global Epigenetics Market can be segmented by product type, into Reagents & Kits, Instruments and Others. By Application into Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, and Others. Based on Technology into DNA Methylation, Histone Methylation, Histone Acetylation, Large non - coding RNA, MicroRNA modification, Chromatin structures. Based on Region, the Epigenetics Market is segmented into North America, Europe, Asia Pacific, Latin America And Middle East & Africa.


North America to Continue Dominating the Epigenetics Market

With a market share of around 40% in 2024, North America was at the forefront of the market. Governments in the region are supporting ongoing Epigenetics research by providing financing. Aside from that, the existence of superior healthcare facilities and ongoing advances in diagnostic methods are boosting the regional markets growth. The expanding elderly population and high acceptance of technologically improved facilities are expected to drive the market in North America.

{{Map_Image}}


Key Players:

Some of the players are Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad Laboratories (US), New England Biolabs (US), Agilent (US), QIAGEN (Netherlands), Zymo Research (US), PerkinElmer (US), and Diagenode (Belgium).


The Epigenetics market is segmented as follows:

Market Segmentation

ParameterDetails
Segment Covered

By Product

  • Instruments
  • Reagents & Kits (30.1%)
  • Others

By Application

  • Oncology (34.5%)
  • Autoimmune Diseases
  • Metabolic Diseases
  • CNS/Pain Diseases
  • Cardiovascular Diseases
  • Others

By Technology

  • Methylation (40.1%)
  • Acetylation
  • Phosphorylation
  • Other Technologies

By Region

  • North America (U.S., Canada, Mexico) (40.1%)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Illumina (US)
  • Thermo Fisher Scientific (US)
  • Merck Millipore (US)
  • Abcam (UK)
  • Active Motif (US)
  • Bio-Rad Laboratories (US)
  • New England Biolabs (US)
  • Agilent (US)
  • QIAGEN (Netherlands)
  • Zymo Research (US)
  • PerkinElmer (US)
  • and Diagenode (Belgium) are the major companies operating in Epigenetics Market.
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options


Report coverage & Deliverables

Our PDF Reports And Online Dashboard Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

Related Reports

Healthcare ITHealthcare IT

Veterinary Care Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Veterinary Care Market, focusing on crucial trends, advancement in technology, and the competitive landscape. With an emphasis on..

From $4299

Healthcare ITHealthcare IT

Surgical Imaging Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Surgical Imaging Market, focusing on crucial trends, advancement in technology, and the competitive landscape. With an emphasis on..

From $4299

Healthcare ITHealthcare IT

Healthcare BPO Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Healthcare BPO Market, focusing on crucial trends, advancement in technology, and the competitive landscape. With an emphasis on..

From $4299

Healthcare ITHealthcare IT

Pen Needles Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Pen Needles Market, focusing on crucial trends, advancement in technology, and the competitive...

From $4299

Energy & PowerEnergy & Power

Petroleum Cargo Inspection and Testing Services Market

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Petroleum Cargo Inspection and Testing Market, focusing on crucial trends, advancement in technology, and the competitive...

From $4299

Energy & PowerEnergy & Power

Petroleum Cargo Inspection and Testing Services Market

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Petroleum Cargo Inspection and Testing Market, focusing on crucial trends, advancement in technology, and the competitive...

From $4299

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Epigenetics Market: Solutions, Growth & Trends | 2025-2035